China Energy Storage Technology Development Limited — Capital/Financing Update 2021

Jun 30, 2021

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

This announcement appears for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for the securities of the Company.

Link-Asia International MedTech Group Limited 環亞國際醫療科技集團有限公司

(incorporated in the Cayman Islands with limited liability)

(Stock code: 1143)

COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE

Sole Placing Agent

Financial Adviser

Euto Capital Partners Limited

The Board is pleased to announce that the conditions of the Placing as set out in the Placing Agreement had been fulfilled, and the Completion took place on 30 June 2021 in accordance with the terms and conditions of the Placing Agreement.

A total of 102,704,000 Placing Shares have been successfully placed by the Sole Placing Agent to not less than six Placees at the Placing Price of HK$0.224 per Placing Share pursuant to the terms and conditions of the Placing Agreement.

Reference is made to the announcement of Link-Asia International MedTech Group Limited (the ‘‘Company’’) dated 15 June 2021 (the ‘‘Announcement’’) in relation to the placing of new shares under general mandate. Unless otherwise stated, capitalised terms used in this announcement shall have the same meanings as defined in the Announcement.

– 1 –

COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE

The Board is pleased to announce that the conditions of the Placing as set out in the Placing Agreement had been fulfilled, and the Completion took place on 30 June 2021 in accordance with the terms and conditions of the Placing Agreement.

A total of 102,704,000 Placing Shares have been successfully placed by the Sole Placing Agent to not less than six Placees at the Placing Price of HK$0.224 per Placing Share pursuant to the terms and conditions of the Placing Agreement, representing approximately 16.67% of the issued share capital of the Company as enlarged by the allotment and issue of the Placing Shares immediately after the Completion.

To the best of the Directors’ knowledge, information and belief, having made all reasonable enquiries, each of the Placees and, where appropriate, their respective ultimate beneficial owners, are professional or other institutional investor(s) independent of the Company, the Directors, Substantial Shareholders and chief executive (as those terms defined in the Listing Rules) of the Company, its subsidiaries and their respective associates (as defined in the Listing Rules).

The net proceeds (after deduction of commission and other expenses of the Placing) from the Placing amounted to approximately HK$22.21 million. The Company intends to use such net proceeds as to: (i) approximately HK$10 million for developing the Group’s assisted reproduction medical technology business, and (ii) remaining balance of approximately HK$12.21 million for general working capital of the Group.

EFFECTS ON SHAREHOLDING STRUCTURE OF THE COMPANY

The table below sets out the shareholding structure of the Company immediately before and after the Completion:

Name of the Shareholders Power Port Holdings Limited (Note 1) Keywan Global Limited (Note 2) Mr. Cao Longbing (Note 3) Hearts Capital SPC — Hearts SP2 (Note 3) The Placees Other public Shareholders Total	Immediately before the Completion Number of Shares % 75,817,000 14.76 49,500,000 9.64 428,000 0.08 35,930,000 7.00 — — 351,863,570 68.52 513,538,570 100.00	Immediately after the Completion Number of Shares % 75,817,000 12.30 49,500,000 8.03 428,000 0.07 35,930,000 5.83 102,704,000 16.67 351,863,570 57.10 616,242,570 100.00	Immediately after the Completion Number of Shares % 75,817,000 12.30 49,500,000 8.03 428,000 0.07 35,930,000 5.83 102,704,000 16.67 351,863,570 57.10 616,242,570 100.00
			100.00

Notes:

(1) Power Port Holdings Limited, which is a company incorporated in the British Virgin Islands, is whollyowned by Ms. Yang Changrong.

– 2 –

• (2) Keywan Global Limited, which is a company incorporated in the British Virgin Islands, is wholly-owned by Mr. He Xiaoming.

• (3) Hearts Capital SPC — Hearts SP2, which is a company incorporated in the Cayman Islands, is whollyowned by Hearts Capital (Asia) Limited, which in turn is 70% controlled by Mr. Cao Longbing. Mr. Cao Longbing is also interested in 428,000 Shares. Long Asia Asset Management (HK) Limited is the investment manager of Hearts Capital SPC — Hearts SP2 and is therefore deemed to be interested in the shares owned by Hearts Capital SPC — Hearts SP2 under the SFO.

• (4) Certain percentage figures included in the above table have been subject to rounding adjustments. Accordingly, figures shown as totals may not be an arithmetic aggregation of the figures preceding them.

On behalf of the Board Link-Asia International MedTech Group Limited Lin Dailian Chairman and executive Director

Hong Kong, 30 June 2021

As at the date of this announcement, the Board comprises Mr. Lin Dailian (Chairman), Mr. Wang Guozhen, Mr. Duan Chuanhong and Mr. Xia Xiaobing as executive Directors; Mr. Li Huiwu, Mr. Yang Weidong and Mr. Chak Chi Shing as independent non-executive Directors.

– 3 –